Who is sponsoring NCT04263805?

NCT04263805 is sponsored by Assistance Publique - Hôpitaux de Paris.

What drugs are being tested in NCT04263805?

Interventions in NCT04263805: Vignette with emphasis on research climate.

What condition does NCT04263805 study?

NCT04263805 studies The Study Focus on no Specific Condition.

Is NCT04263805 still recruiting?

NCT04263805 is currently status unknown. Last updated 11 February 2020.

Last reviewed 2020-02-11 · How we verify

NCT04263805

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Vignette-based Randomized Controlled Trial to Evaluate the Impact of Research Climate on Research Practices of Doctoral Students

Status unknown NA Last updated 11 February 2020

What this trial tests

NA trial testing Vignette with emphasis on research climate in The Study Focus on no Specific Condition in 300 participants. Status unknown.

Timeline

1 February 2020

Primary endpoint
31 December 2020

31 December 2020

Quick facts

Lead sponsor	Assistance Publique - Hôpitaux de Paris
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	300
Start date	1 February 2020
Primary completion	31 December 2020
Estimated completion	31 December 2020
Sites	1 location across France

Drugs / interventions tested

Vignette with emphasis on research climate

Conditions studied

The Study Focus on no Specific Condition — all drugs for The Study Focus on no Specific Condition →

Sponsor

Assistance Publique - Hôpitaux de Paris — full company profile →

Who can join

18 and older, any sex, with The Study Focus on no Specific Condition. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the impact of research climate on PhD students' research practice (i.e., an environment where their peer (i.e., a post-doc researcher) had detrimental practice in a similar situation)

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Biomedical doctoral students' research practices when facing dilemmas: two vignette-based randomized control trials.
Nguyen VT, Sharp MK, Superchi C, Baron G, et al · · 2023 · cited 2× · PMID 37773192 · DOI 10.1038/s41598-023-42121-1

Verify or expand the search:

Other Assistance Publique - Hôpitaux de Paris trials

Trials by the same sponsor.

NCT07443436 — Immunomodulatory Treatment of Interstitial Lung Disease Associated With Surfactant Related Gene Variants · Phase 2 · not yet recruiting
NCT07499492 — Red Blood Cell Transfusion to Optimize Extubation · NA · not yet recruiting
NCT07379918 — Real-life Evaluation of Endopredict® in Early HR+/HER2- Breast Cancer · recruiting
NCT07473869 — Smartphone Application for Automated Measurement of Capillary Refill Time (CRT) · not yet recruiting
NCT07505394 — Efficacy of a Prediction Model-based Algorithm to PREVENT Drug-induced Impulse Control Disorders in Parkinson's Disease · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04263805 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assistance Publique - Hôpitaux de Paris
Last refreshed: 11 February 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04263805.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing